HINOVA PHARMA
Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.
HINOVA PHARMA
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Chengdu, Sichuan, China
Country:
China
Website Url:
http://www.hinovapharma.com
Total Employee:
11+
Status:
Active
Contact:
(028) 8505 8465
Total Funding:
219.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Euro DigiCert SSL Pound Sterling Japanese Yen Encryption Everywhere Alibaba
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Current Employees Featured
Founder
Investors List
Sinopharm-CICC
Sinopharm-CICC investment in Series C - Hinova Pharma
CCB International
CCB International investment in Series C - Hinova Pharma
Huarong Rongde Asset Management
Huarong Rongde Asset Management investment in Series C - Hinova Pharma
Founder H Fund
Founder H Fund investment in Series C - Hinova Pharma
Hongtai Capital Holdings
Hongtai Capital Holdings investment in Series C - Hinova Pharma
DNV capital
DNV capital investment in Series C - Hinova Pharma
Tigermed
Tigermed investment in Series C - Hinova Pharma
Infinity Group
Infinity Group investment in Series C - Hinova Pharma
Sealand Securities
Sealand Securities investment in Series C - Hinova Pharma
Shenzhen Investment Holdings
Shenzhen Investment Holdings investment in Series C - Hinova Pharma
Official Site Inspections
http://www.hinovapharma.com Semrush global rank: 8.74 M Semrush visits lastest month: 261
- Host name: 47.108.189.216
- IP address: 47.108.189.216
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Hinova Pharma"
Our Company - Hinova Pharmaceuticals Inc.
Hinova (688302. SH) is an international and clinical-stage pharmaceutical company focusing on developing new therapeutics for cancers and metabolic syndromes through PROTAC and …See details»
Hinova Pharmaceuticals Inc.
Enrollment of Phase III clinical trial for HC-1119 in China completed Phase II clinical trial for HP501 completed Phase II clinical trial for HP558 approved by NMPA Phase I clinical trial for …See details»
海创药业股份有限公司【官网】
海创药业是一家基于PROTAC靶向蛋白降解和氘代药物研发等技术平台，以开发具有重大临床需求的Best-in-class、First-in-class药物为目标的国际化创新药企业。公司专注于肿瘤、代谢疾病 …See details»
Hinova Pharma - Crunchbase Investor Profile & Investments
Hinova Pharma is a pharmaceutical company. Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor …See details»
Hinova Pharmaceuticals Inc. | LinkedIn
Hinova (688302.SH) is an international and clinical-stage pharmaceutical company focused on developing new therapeutics for cancers and metabolic syndromes through PROTAC and …See details»
Org Chart Hinova Pharma - The Official Board
For each of our 1,265,277 listed executives, discover their exact roles and their biographies.See details»
Hinova Pharma - Craft
Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery …See details»
Hinova Pharmaceuticals - Company Profile - Tracxn
Nov 17, 2024 Hinova Pharmaceuticals - Develops small molecule based drug for multiple disease treatment. Public Company. Raised a total funding of $187M over 2 rounds from 18 …See details»
Hinova Pharmaceuticals - Overview, News & Similar companies
Feb 6, 2023 Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC) CHENGDU, China, July 5, 2024 …See details»
Hinova Pharmaceuticals - PitchBook
Hinova Pharmaceuticals General Information Description. Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class …See details»
Company Hinova Pharmaceuticals Inc. - MarketScreener.com
Feb 4, 2013 Hinova Pharmaceuticals Inc is a Chinese company mainly engaged in the research and development of innovative drugs for critical illnesses. The Company focuses its research …See details»
Executive Team - Hinova Pharmaceuticals Inc.
·Past Deputy Manager, Sihai Tongxing Holding Co. Ltd., Chengdu Wintrue Holding Co.Ltd., China ·Past President of Sichuan Tongtai Zhongying Investment Management Co. Ltd., ChinaSee details»
Hinova Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hinova Pharmaceuticals, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Hinova Pharma | VentureRadar
Website: http://www.hinovapharma.com/ Specializes in researching, developing, and producing high-quality pharmaceuticals using advanced technology to improve patient ...See details»
Hinova Pharmaceuticals - Products, Competitors, Financials, …
Dec 4, 2022 Headquarters Location. Unit 1, 4/F, Building A 5 Keyuan South Rd, Gaoxin District. Chengdu, Sichuan, 610041, China. 86-028-8505-8465See details»
Partnerships - Hinova Pharmaceuticals Inc.
Email:[email protected]. Investors. With the support of the investors, our pipelines have been advanced very quickly. We are expecting to work together with the investors to bring …See details»
Hinova Pharma - VentureRadar
"Haichuang Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the research, development, and production of innovative medical solutions.See details»
Hinova Receives FDA Proceed Authorization for its IND …
WILMINGTON, Del., Feb. 6, 2023 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focusing on developing novel therapeutics for cancers and …See details»
Hinova Pharma - VentureRadar
Similar Companies: Qurient South Korea Publicly Traded Qurient is a spin-off biotechnology company from the Institute Pasteur Korea (IPK) dedicated to developing novel therapeutics …See details»
Press Releases - Hinova Pharmaceuticals Inc.
[email protected] 2025 2024 2023 2022 2021 2020 2019 Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast …See details»